Probing the anticancer mechanism of (-)-ainsliatrimer A through diverted total synthesis and bioorthogonal ligation

Angew Chem Int Ed Engl. 2014 Nov 3;53(45):12111-5. doi: 10.1002/anie.201407225. Epub 2014 Sep 15.

Abstract

Herein, we report an efficient approach for exploring the novel anticancer mechanism of (-)-ainsliatrimer A, a structurally complex and unique trimeric sesquiterpenoid, through a combined strategy of diverted total synthesis (DTS) and bioorthogonal ligation (TQ ligation), which allowed us to visualize the subcellular localization of this natural product in live cells. Further biochemical studies facilitated by pretarget imaging revealed that PPARγ, a nucleus receptor, was a functional cellular target of ainsliatrimer A. We also confirmed that the anticancer activity of ainsliatrimer A was caused by the activation of PPARγ.

Keywords: antitumor agents; bioorganic chemistry; bioorthogonal ligation; diverted total synthesis; target identification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology*
  • HeLa Cells
  • Humans
  • Lactones / chemistry
  • Lactones / pharmacokinetics
  • Lactones / pharmacology*
  • PPAR gamma / agonists
  • Sesquiterpenes / chemistry
  • Sesquiterpenes / pharmacokinetics
  • Sesquiterpenes / pharmacology*
  • Subcellular Fractions / metabolism

Substances

  • Antineoplastic Agents
  • Lactones
  • PPAR gamma
  • Sesquiterpenes
  • ainsliadimer A